Commentary: The ALLHAT Study: implications for the management of resistant hypertension [0.03%]
ALLAHAT研究述评及相关难治性高血压的处理措施
Gregory M Singer,John F Setaro
Gregory M Singer
Marvin Moser,Thomas D Giles,Bonita Falkner et al.
Marvin Moser et al.
Following a hypertension symposium held in Philadelphia, PA, on June 8, 2004, a roundtable discussion was held to discuss the treatment of hypertension in adolescents and children. The participants included Thomas D. Giles, MD, of Louisiana...
Intraindividual blood pressure responses to angiotensin-converting enzyme inhibition and angiotensin receptor blockade [0.03%]
血管紧张素转换酶抑制和血管紧张素受体阻滞的个体血压反应
George S Stergiou,Stamatis P Efstathiou,Leonidas G Roussias et al.
George S Stergiou et al.
This study aims to test the hypothesis that in some hypertensive subjects the blood pressure (BP) response to angiotensin-converting enzyme inhibition differs from that to angiotensin receptor blockade (ARB); a responder to angiotensin-conv...
Angiotensin-converting enzyme i/d polymorphism in patients with malignant hypertension [0.03%]
恶性高血压患者中血管紧张素转换酶基因的插入/删除多态性研究
Eugenia Espinel,Jose Luis Tovar,Javier Borrellas et al.
Eugenia Espinel et al.
The angiotensin-converting enzyme (ACE) gene has been implicated in the manifestation of the phenotype of malignant hypertension (MH). In 1990 the ACE gene polymorphism characterized by the insertion or deletion of a 287-base pair fragment ...
Marayann N Mugo,James R Sowers
Marayann N Mugo
Common questions and answers in the management of hypertension: routine measurement of plasma renin activity in the management of patients with essential hypertension: notes from the 19th Annual ASH Meeting [0.03%]
原发性高血压患者诊室血压测量中关于血浆肾素活性普测的常见问题和解答注释：美国血液学会第19届年会报告摘要
Ari Mosenkis,Raymond R Townsend
Ari Mosenkis